For improved immunotherapy against lung metastasis, researchers designed biomimetic aAPCs (CD-MnOx@CM) using ultrathin MnOx nanoparticles (NPs), which were functionalized with T cell activators (anti-CD3/CD28 mAbs, CD) and tumor cell membranes [123]. Here, CD28 is linked to neoplasm.